The life sciences industry is rapidly changing and highly regulated. We act for clients across the health sector, including NHS Commissioners, NHS and independent health providers and established healthtech companies and start-ups, meaning we’re uniquely placed to manage these challenges and guide clients through regulatory and contractual processes.
Medical devices, appliances and apps are usually highly technical, meaning they are of high value. This means they need to go through extremely rigorous regulatory processes and testing before they can secure approval for use in the market.
At Browne Jacobson, we have specialised teams that advise on different areas of the life sciences sector. Our expertise covers intellectual property (contentious and non-contentious), regulatory, commercial, procurement, data protection, dispute resolution and value add services.
Much of our advice is proactive, guiding clients on the development of new products and services, entry to the UK market, business restructuring or in respect of ongoing regulatory compliance. We’re regularly asked to advise on MHRA regulation, CQC registration, trademark registration, data processing requirements and NHS Provider licensing.
Our expertise also extends to advising clients on the challenges of dealing with digital disruption and digital transformation, including advising on the issues at the forefront of society in the context of those challenges.
Advising management on the acquisition of Quotient Clinical, a provider of outsourced, early stage drug development services to the pharmaceutical industry, from the Quotient Bioresearch Group by Bridgepoint Development Capital.
Advising Bioprojet Pharma S.á.r.l on the UK aspects of a £10.2 million acquisition of Lincoln Medical Limited, which provides drug delivery systems for the treatment of anaphylactic shock.
Acting on Crown Bioscience Inc’s acquisition of Precos - a leading pre-clinical research and development service provider with a focus on oncology.
Acting for a household name in the health sector in defence of allegations of patent infringement in respect of a therapeutically-crucial diagnostic test.
"Browne Jacobson’s health Team can always be relied upon for support through difficult issues which sometimes arise, and they work towards the best resolution quickly."
"All the team are very approachable and use plain English, they return calls on time and keep to schedules as defined. The use of the drop box for documents was especially helpful with large amounts of Patient identifiable information. Have started to offer good training sessions to update on case law, LPS and modernisation of the Mental Health Act."
"Browne Jacobson has mastered the art of being friendly and approachable whilst providing high quality legal advice which represents excellent value for money. They understand the needs and pressures on my organisation and support us superbly at times of difficulty."
"The relationship between solicitors within the team, paralegals and other legal support and barristers on a case is extremely collaborative- more so than any other firm I work with. There is very much a team approach in conducting complex cases which is essential to benefit the client concerned."
The Chancellor’s recent mini-budget provided a significant announcement for business as it was confirmed that the off-payroll working rules (known as “IR35”) put in place for public and private sector businesses from 2017 and 2021 will be scrapped from April 2023.
The Federation of Small Businesses (FSB) has released a report setting out the impact of new and changing regulations arising from the pandemic on small businesses across the UK.
As has been widely reported this week, some 3,000 UK workers are taking part in a six month trial to assess the viability of a four-day working week without any reduction in their normal pay.
In Nissan v Passi, the High Court recently considered the issue of an employee retaining confidential documents belonging to his former employer in the context of the employer’s application for an injunction seeking the return of such documents from the employee.
Browne Jacobson’s award-winning corporate dealmakers have advised the shareholders of Medline Scientific on its sale to diversified global provider of life science reagents, tools, instruments and other consumables, Calibre Scientific for undisclosed consideration.
Browne Jacobson has appointed Peter Allen as Partner to its Manchester office, as it continues to grow its North West corporate practice.
Browne Jacobson has advised BGF on its investment in Nottingham life sciences incubator BioCity. The investment has also been supported by Blue Skies Investments (BSI).
